VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹584 Cr | ₹542 Cr | ₹495 Cr | ₹538 Cr | ₹494 Cr |
What is the latest Total Expenditure of VENUS REMEDIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹584 Cr |
| Mar2024 | ₹542 Cr |
| Mar2023 | ₹495 Cr |
| Mar2022 | ₹538 Cr |
| Mar2021 | ₹494 Cr |
How is Total Expenditure of VENUS REMEDIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹584 Cr | 7.84 | |
| Mar2024 | ₹542 Cr | 9.36 | |
| Mar2023 | ₹495 Cr | -7.91 | |
| Mar2022 | ₹538 Cr | 8.84 | |
| Mar2021 | ₹494 Cr | - | |
Compare Total Expenditure of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,051.4 Cr | 5% | 3.2% | 157.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 5% |
3.2% |
157.7% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses